Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.

Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy.

Amyloid Related Imaging Abnormalities (ARIA) represent the major severe side effect of amyloid-beta (Aβ) immunotherapy for Alzheimer’s disease (AD). Early biomarkers of ARIA represent an important challenge to ensure safe and beneficial effects of immunotherapies, given that different promising clin...

Full description

Bibliographic Details
Main Authors: Jacopo C. DiFrancesco, Martina eLongoni, Fabrizio ePiazza
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-09-01
Series:Frontiers in Neurology
Subjects:
Immunotherapy
Alzheimer’s disease
BAN2401
solanezumab
aducanumab
Cerebrospinal fluid biomarker
Online Access:http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00207/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fneur.2015.00207/full

Similar Items